10 Worst Performing Biotech Stocks in 2024
Biotechnology stocks are among the most volatile in the market due to their high risk.
Immunovant Inc. (IMVT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Deep Track Capital David Kroin | 4,347,464 | $123,946,199 | +51% | 3.93% |
| 2. | Armistice Capital Steven Boyd | 3,548,000 | $101,153,480 | +5% | 1.61% |
| 3. | Perceptive Advisors Joseph Edelman | 2,378,762 | $67,818,505 | +24% | 1.43% |
| 4. | Viking Global Andreas Halvorsen | 2,320,902 | $66,168,916 | 0.24% | |
| 5. | Woodline Partners Michael Rockefeller And Karl Kroeker | 1,414,977 | $40,340,994 | -23% | 0.33% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $38.00 | 1,526,316 | 79,805,331 | 2023-10-02 | Filing | ||
| $6.00 | 416,667 | 73,805,331 | 2022-10-06 | Filing | ||
| $5.60 | 15,000 | Director | 20,000 | 2022-09-30 | Filing | |
| $5.81 | 20,000 | Director | 393,358 | 2022-09-29 | Filing | |
| $8.24 | 18,247 | Director | 58,447 | 2021-08-27 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.45 | 3,650 | Officer | 319,228 | 2024-11-20 | Filing | |
| $25.45 | 3,353 | Officer | 361,791 | 2024-11-20 | Filing | |
| $25.45 | 4,174 | Officer | 331,169 | 2024-11-20 | Filing | |
| $25.45 | 16,692 | Officer, Director | 978,097 | 2024-11-20 | Filing | |
| $29.53 | 4,361 | Officer | 322,878 | 2024-10-23 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,875,822 | $331,808,380 | 0.02% | |
| 2. | 5,827,798 | $245,525,131 | 0% | |
| 3. | 4,530,716 | $190,879,067 | 0% | |
| 4. | 3,216,376 | $135,505,921 | 0% | |
| 5. | 1,398,372 | $58,913,412 | 18.83% |
News See All
10 Worst Performing Stocks to Buy on the Dip
Capital markets demonstrated increased volatility starting in August 2024 and continuing in September 2024. That being said, strong rallies followed numerous negative performance days.
Should You Hold Immunovant (IMVT)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
Billionaire Steve Cohen and Insiders are Buying These 5 Stocks
This article presents an overview of Billionaire Steve Cohen and Insiders are Buying These 5 Stocks. For a detailed overview of such stocks, read our article, Billionaire Steve Cohen and Insiders ...
11 Oversold Biotech Stocks To Buy Right Now
In this article, we will be taking a look at 11 oversold biotech stocks to buy right now.
10 Stocks George Soros and Insiders Are Crazy About
In this article, we will take a detailed look at the 10 Stocks George Soros and Insiders Are Crazy About. For a quick overview of such stocks, read our article 5 Stocks George Soros and Insiders Are...
5 Oversold Healthcare Stocks To Buy Right Now
In this article, we will be taking a look at 5 oversold healthcare stocks to buy right now.
Should You Invest in Immunovant (IMVT)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
Immunovant (IMVT) Rose on Positive Clinical Trial
Chartwell Investment Partners, LLC, an affiliate of Carillon Tower Advisers, Inc., released the “Carillon Chartwell Small Cap Value Fund” third quarter 2023 investor letter.
11 Stocks Insiders and Billionaires Are Crazy About
In this article, we will take a detailed look at the 11 Stocks Insiders and Billionaires Are Crazy About. For a quick overview of such stocks, read our article 5 Stocks Insiders and Billionaires Are...